Ann Intern Med 2022 May 24. Epub 2022 May 24.
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland (M.C.S., C.J.L., A.R.M., B.P.H., K. Tolstenko, R.W.K., G.M., G.M.O., K. Trihemasava, B.D.K., V.S., J.S.J., C.M.B., J.B., S.M., T.C., H.C.L.).
Background: A substantial proportion of persons who develop COVID-19 report persistent symptoms after acute illness. Various pathophysiologic mechanisms have been implicated in the pathogenesis of postacute sequelae of SARS-CoV-2 infection (PASC).
Objective: To characterize medical sequelae and persistent symptoms after recovery from COVID-19 in a cohort of disease survivors and controls. Read More